Alex Lynn
PEI’s latest GP-led Secondaries Report explores a market that continues to break new ground, despite 2022’s apparent slowdown.
The asset manager will pursue yuan-denominated LP-led and GP-led transactions from a discretionary pool of client capital, according to Asia co-head Mingchen Xia.
Speaking at the HKVCA’s annual forum, Colin Sau, managing partner of TR Capital, said the firm is increasing its focus on China in 2023 after a slowdown in recent years.
The former head of alternative investments at healthcare provider Kaiser Permanente is expected to focus on growth equity, VC and secondaries activity.
Pension giant is reviving plans that were scrapped last year, head of the strategic alternative investments Jeryang Lee told delegates at the PDI: Seoul Forum.
Diagnostics business The Binding Site was part of a group of companies involved in the firm's landmark 2018 GP-led secondaries process.
Ivan Chu and Jonathan Lau of Welkin Capital Management discuss why secondaries is so important for its $300m listed fund.
TR Capital's Colin Sau told delegates at Wednesday's HKVCA China Private Equity Summit that GPs are favouring domestic liquidity routes for certain industries.
Many public institutions in the US are exploring portfolio sales thanks to a confluence of factors that has left them at, or above, their private equity allocations.
GP-led activity is picking up thanks to a decline in exit activity during the pandemic and rising familiarity with the practice.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: